These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26049069)

  • 21. [Current status of the management of venous thromboembolism in Japan].
    Nakamura M
    Nihon Rinsho; 2014 Jul; 72(7):1298-302. PubMed ID: 25163325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding.
    Spaander MC; Hoekstra J; Hansen BE; Van Buuren HR; Leebeek FW; Janssen HL
    J Thromb Haemost; 2013 Mar; 11(3):452-9. PubMed ID: 23289370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercoagulability in cirrhosis: causes and consequences.
    Tripodi A; Anstee QM; Sogaard KK; Primignani M; Valla DC
    J Thromb Haemost; 2011 Sep; 9(9):1713-23. PubMed ID: 21729237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the dose of warfarin for therapeutic anticoagulation.
    Sharma NK; Routledge PA; Rawlins MD; Davies DM
    Thromb Haemost; 1982 Jun; 47(3):230-1. PubMed ID: 7112495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation in patients with liver cirrhosis: complication or therapeutic opportunity?
    Jairath V; Burroughs AK
    Gut; 2013 Apr; 62(4):479-82. PubMed ID: 23300140
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetic ketoacidosis complicated by generalized venous thrombosis: a case report and review.
    Cherian SV; Khara L; Das S; Hamarneh WA; Garcha AS; Frechette V
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):238-40. PubMed ID: 22356837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
    N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of deep vein thrombosis in cancer patients.
    Jahanzeb M
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
    [No Abstract]   [Full Text] [Related]  

  • 29. Anticoagulants: Major Advances Without Clear Consensus.
    Hohl RJ
    Clin Pharmacol Ther; 2016 Aug; 100(2):116-8. PubMed ID: 27393187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications].
    Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Khasanova ZB; Postnov AIu; Kirienko AI
    Ter Arkh; 2011; 83(12):43-8. PubMed ID: 22416444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The venous side: current directions in anticoagulant therapy.
    Kaatz S
    J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S17-21. PubMed ID: 11191117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cirrhosis and coagulation : implications for clinical practice].
    Nguyen F; Bauer S; Benzarti S; De Brito Nunes M; Levrat E
    Rev Med Suisse; 2021 Sep; 17(749):1495-1498. PubMed ID: 34495584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of the patient with deep vein thrombosis.
    Weismantel D
    J Fam Pract; 2001 Mar; 50(3):249-56. PubMed ID: 11252215
    [No Abstract]   [Full Text] [Related]  

  • 35. Portal vein thrombosis: an unexpected finding in a 28-year-old male with abdominal pain.
    Ferguson JL; Hennion DR
    J Am Board Fam Med; 2008; 21(3):237-43. PubMed ID: 18467536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation therapy in neonates, children and adolescents.
    Hepponstall M; Chan A; Monagle P
    Blood Cells Mol Dis; 2017 Sep; 67():41-47. PubMed ID: 28552474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy with anticoagulant drugs.
    O'Reilly RA
    Ration Drug Ther; 1974 Jun; 8(6):1-7. PubMed ID: 4845147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.